BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7287594)

  • 1. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR; Feng JB; Liang F; Zeng SX; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical modification of anthracycline antibiotics. I. Demethoxycarbonylation, 10-epimerization and 4-o-methylation of aclacinomycin A.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1323-30. PubMed ID: 6941951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of anthracycline antibiotics. V. Synthesis of 2-hydroxyaclacinomycin A by chemical glycosidation.
    Tanaka H; Yoshioka T; Yoshimoto A; Shimauchi Y; Ishikura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1983 May; 36(5):601-3. PubMed ID: 6874576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunomodulation by antitumor antibiotics].
    Ishizuka M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Ishikura T
    J Antibiot (Tokyo); 1982 Mar; 35(3):312-20. PubMed ID: 6951827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction and hydrolysis of 2-hydroxyaclacinomycin A.
    Matsuzawa Y; Oki T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1495-7. PubMed ID: 7319910
    [No Abstract]   [Full Text] [Related]  

  • 8. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
    DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
    Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
    [No Abstract]   [Full Text] [Related]  

  • 9. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
    Li ZR; Feng JB; Han R; Yin MB; Xia LJ
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of aclacinomycin B on nucleolar ultrastructure and function of RNA synthesis in human gastric cancer cells].
    Li LH; Wang YS; Li GR
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):266-71. PubMed ID: 2959026
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.
    Zenebergh A; Baurain R; Trouet A
    Cancer Chemother Pharmacol; 1982; 8(2):243-9. PubMed ID: 6955072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
    Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hydroxyaclacinomycins A and B by a new recombinant strain and their antitumor activities.
    Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):277-86. PubMed ID: 1880910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
    Soga K; Furusho H; Mori S; Oki T
    J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 19. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis of the dipeptide derivatives of daunomycinone and adriamycinone].
    Ge P; Wang ZQ; Zhang CN
    Yao Xue Xue Bao; 1987 Apr; 22(4):254-63. PubMed ID: 3687444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.